We found a relatively low concentration of EGCG could re-sensitize hormone-resistant breast cancers cells to the hormone antagonist, tamoxifen, by re-expression of functional ERα in ERα-negative breast cancer cells. Here, ESR1 is linked to breast carcinoma.